APA (7th ed.) Citation

Pujol, J., & Thomas, M. (2014). Long-term and low-grade safety results of a phase III study (PARAMOUNT): Maintenance Pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with Pemetrexed plus Cisplatin for advanced nonsquamous non-small-cell lung cancer. Clinical lung cancer, 15(6), . https://doi.org/10.1016/j.cllc.2014.06.007

Chicago Style (17th ed.) Citation

Pujol, Jean-Louis, and Michael Thomas. "Long-term and Low-grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-small-cell Lung Cancer." Clinical Lung Cancer 15, no. 6 (2014). https://doi.org/10.1016/j.cllc.2014.06.007.

MLA (9th ed.) Citation

Pujol, Jean-Louis, and Michael Thomas. "Long-term and Low-grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-small-cell Lung Cancer." Clinical Lung Cancer, vol. 15, no. 6, 2014, https://doi.org/10.1016/j.cllc.2014.06.007.